Clin2
NCT07319286Possibly a fitEnrolling by invitation

GLP-1 drug for period problems in teens with type 1 diabetes

Menstrual IrregularitiesType1 Diabetes MellitusGlucagon-Like Peptide-1 Receptor AgonistsFemale Reproductive Health

Treatments studied

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests whether a GLP-1 receptor agonist can help improve irregular periods in teenage girls with type 1 diabetes. It's for girls aged 12 to 18 who have had their period for at least 2 years, use a continuous glucose monitor, and have higher blood sugar levels (HbA1c of 7% or more).

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
12 years to 18 years
Study type
Interventional

Who can take part

  • You must be a girl between 12 and 18 years old
  • You must have type 1 diabetes and use a continuous glucose monitor (CGM)
  • You need to have had your period for at least 2 years
  • Your latest HbA1c should be 7% or higher (meaning your blood sugar is higher than ideal)
  • You cannot have other medical conditions that cause irregular periods, like thyroid problems or autoimmune diseases
  • You cannot have had severe low blood sugar in the past year or a history of pancreatitis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07169136Recruiting
GLP-1 medicine for PCOS in teens with obesity

This trial tests if a medicine called a GLP-1 agonist (like semaglutide) can help with hormone and ovulation problems in adolescent girls with PCOS and obesity. It aims to improve irregular periods and other PCOS symptoms.

Jacksonville, Florida
NCT04731272Recruiting· Phase 2
Weekly GLP-1 medicine for blood sugar issues in adults with CF

This Phase 2 trial tests a weekly GLP-1 medicine (dulaglutide) to improve blood sugar control in adults with cystic fibrosis (CF) who have trouble managing glucose. It may help people with CF-related prediabetes or diabetes by improving how their body handles sugar.

Aurora, Colorado
NCT06338553Recruiting· Early Phase 1
GLP-1 drug for early type 1 diabetes

This study tests whether a GLP-1 receptor agonist (a type of medicine that helps control blood sugar and appetite) can improve metabolic health in people with early type 1 diabetes. It may be an option if you have already taken teplizumab to delay the disease or were recently diagnosed with type 1 diabetes.

Nashville, Tennessee
NCT06411210Recruiting· Phase 2
Weight loss medication for young adults with type 1 diabetes

This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.

New Haven, Connecticut
NCT07194291Not yet recruiting
Period changes in girls with diabetes

This study looks at how periods change in girls with diabetes compared to girls without diabetes. It aims to understand if diabetes affects menstrual cycles in teenage girls.

NCT05258292Recruiting
Track blood sugar changes with your period in type 1 diabetes

This study monitors how your blood sugar (glucose) changes across your menstrual cycle using a continuous glucose monitor. It may help researchers understand patterns that could improve diabetes care around monthly hormonal changes.

Montreal, Quebec

Hear when a new Menstrual Irregularities trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.